Datroway is an antibody drug conjugate discovered by Tokyo-based pharmaceutical maker Daiichi Sankyo. It is being jointly developed and commercialised with Cambridge, England-based AstraZeneca PLC.

Clever Culture is quietly automating one of pharma’s most unforgiving jobs , turning a regulatory headache into a scalable ...

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY ® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult ...

TROPION-Lung17 Clinical Update: What Investors Should Watch in AstraZeneca and Daiichi Sankyo’s Next Lung Cancer Catalyst ...

Fosun is joining the fray through its subsidiary Yao Pharma, which has granted Pfizer an exclusive worldwide license to ...

The European Medicines Agency has validated the Type II Variation marketing authorization application for Datroway as monotherapy for the ...

IonQ’s quantum technologies are poised to reshape industries, and health care is one of the most promising frontiers.

JNJ wins FDA approval for a subcutaneous version of Rybrevant, cutting treatment time to minutes and boosting convenience across NSCLC indications.

Trulieve Cannabis Corp. ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., applauds action taken by the Trump Administration to reclassify marijuana to Schedule ...

US President Donald Trump has been criticised for making a 'basic' mathematical error during a White House speech, as he ...

Tilray Medical, a division of Tilray Brands, Inc. ("Tilray" or the "Company") and a global leader in medical cannabis healthcare, today confirmed its planned strategic framework to advance its U.S.

President Donald Trump held a speech where he reflected on the impact he'd had during the first year of his second ...